Dabrafenib

DabrafenibDabrafenib is a compound used as a serine threonine protein kinase B Raf inhibitor for oncology research. It competitively inhibits V600E BRAF gene mutations which are characteristic in melanoma cancers. Inhibition of B Raf proteins, by dabrafenib, interrupts mitogen activated protein kinase extracellular signal regulated kinase (MAPK ERK) pathways, which regulate cell growth. This action halts cell proliferative activity and engages apoptosis.

Tylosin tartrate is a macrolide antibiotic isolated from Streptomyces fradiae

Compatible with downstream applications

Geniposide research in correlation with formaldehyde has proved it to be an inhibitor of misfolding and aggregation of Tau protein and β amyloid protein

Tamoxifen citrate is an anti-cancer agent and protein kinase C inhibitor

5-Methoxyindole-3-acetic acid itself has antibacterial properties

Sulfasalazine is a conjugate molecule composed of sulfapyridine linked to 5-aminosalicylic acid through an azo bond

CF®680R is excellent for labeling antibodies

-glucoside on insulin binding to solubilized membrane receptors

It provides efficient selection across bacterial

Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms

choline chloride can be used as a cell culture media supplement

Ingenol mebutate diminished relapse rates of mice tumors in vivo and in vitro by inducing neutrophil recruiting and activating pathways